We then identified LCP1 as perhaps the most critical gene for bariatric surgery to improve liver function and demonstrated its relevance to the innate and adaptive immune system involved in the pathogenesis of NAFLD. Here, LCP1 is linked to metabolic dysfunction-associated steatotic liver disease.